Early CDC testing finds encouraging recognition of sampled flu viruses. The denominators explain why those results cannot tell you a vaccine's real-world protection rate.
Health
Nara Organics' nationwide recall after three infant botulism cases did not threaten U.S. formula supply, but it did show how quickly a premium trust story can collapse once CDC and FDA warnings replace marketing language.
Health
A June 14, 2026 burst of fresh reporting pushed an old blind spot back into view: adults with ADHD traits keep showing up disproportionately in chronic-pain research, and the best new evidence suggests the overlap may run through anxiety, depression and catastrophic pain thinking as much as through pain itself.
Health
The FDA's adult-only authorization of four Glas vape pods did not erase the core family problem: youth vaping is down from its peak, but it remains common, overwhelmingly flavored and deeply tied to nicotine dependence. That is why the smarter response at home is a calm, specific conversation about nicotine, not a one-night panic speech.
Health
Two Ebola-related deaths reported at Kpangba's displacement site in eastern Congo changed the outbreak's center of gravity. Once the virus reaches a crowded camp, containment stops being only a clinical question and becomes a test of shelter space, trust, and movement control.
Health
The new ACOG maternal immunization schedule is not just another clinical chart. It is a public sign that obstetric care groups no longer trust federal vaccine messaging to stay clear enough for pregnant patients and their clinicians.
Health
U.S. measles cases surpassing 2,000 again is not just a count. It is a warning that immunity gaps are turning a preventable disease into a recurring outbreak pattern.